BGBurak Emre Gilik

Burak Emre Gilik

*This is an algorithmically generated author record based on publicly available information.

Current Organizations / Institutes

The organizations/institutes from the scholar's latest article


Burak Emre Gilik has a total of 17 co-authors. Here are the top co-authors by number of shared publications:


Latest Publications

  • Open Access

    Acute severity, immunonutritional status, and admission source as predictors of ICU mortality in acute exacerbation of COPD

    by Mahmut Yilmaz, Mehmet Celal Ozturk, Rahime Aydin Kayali, Ozcan Alpdogan, Burak Emre Gilik, Enis Behcet Agirdici, Huseyin Ozkarakas

    Background: Chronic obstructive pulmonary disease (COPD) is a major global health burden associated with substantial morbidity and mortality. Acute exacerbations of COPD (AECOPD) frequently require admission to the intensive care unit (ICU). Despite advances in critical care, outcomes among critically ill patients with AECOPD remain heterogeneous, and mortality remains high. Conventional severity scores, such as the Acute Physiology and Chronic Health Evaluation II (APACHE II) and Sequential Organ Failure Assessment (SOFA), primarily reflect acute physiological derangement but may not fully capture systemic inflammation and nutritional status, recognized as determinants of outcome in AECOPD. Methods: This retrospective observational study was conducted in a newly opened tertiary-care hospital and included patients admitted to the ICU with AECOPD between 14 October 2023 and 29 February 2024. Demographic characteristics, comorbidities, admission source, and admission laboratory parameters were recorded, while APACHE II and SOFA scores were calculated using physiological data from the first 24 h of ICU admission. Inflammation-based indices included the neutrophil-to-lymphocyte ratio, systemic inflammation response index, C-reactive protein–based ratios, and the CALLY index. Nutritional and immune status were assessed using the Prognostic Nutritional Index(PNI) and the modified Nutrition Risk in the Critically Ill (mNUTRIC) score. The primary outcome was ICU mortality. Univariable and multivariable logistic regression analyses were performed, and discrimination was assessed using the area under the receiver operating characteristic curve. Results: A total of 477 patients were included; most were male and admitted via the emergency department. Non-survivors had higher APACHE II and SOFA scores, greater systemic inflammation, and poorer nutritional status at ICU admission. Several inflammation-based indices were associated with ICU mortality in unadjusted analyses. However, these indices were not included in the final multivariable model because of their overlapping components and the prespecified variable-selection framework; therefore, their independent prognostic contributions after adjustment for disease severity could not be established. In contrast, PNI remained a robust independent predictor. In multivariable analysis, APACHE II score, PNI, and admission source remained independently associated with ICU mortality. Inter-hospital transfer was associated with significantly higher adjusted odds of ICU mortality compared with emergency department admission, although this estimate was based on a small subgroup and should be interpreted with caution; admission from hospital wards was associated with a modest but statistically significant increase in risk (adjusted OR 2.01, 95% CI 1.02–3.95; p = 0.042). The final model showed strong discrimination (AUC 0.896, 95% CI 0.862–0.930). Conclusions: ICU mortality in critically ill patients with AECOPD reflects combined effects of disease severity, immunonutritional status, and admission characteristics. Integrating conventional severity scores with immunonutritional assessment improves prognostic discrimination and may support risk stratification after external validation.

  • Open Access

    Prognostic value of mNUTRIC and nutritional indices, including early change, for ICU mortality in older adults with AECOPD

    by Mahmut Yilmaz, Rahime Aydin Kayali, Mehmet Celal Ozturk, Burak Emre Gilik, Huseyin Ozkarakas

    Background: Malnutrition is common in older adults with acute exacerbation of chronic obstructive pulmonary disease (AECOPD) requiring intensive care unit (ICU) admission and is associated with adverse outcomes. We aimed to evaluate the prognostic value of the Prognostic Nutritional Index (PNI) and its early change (ΔPNI) for predicting ICU mortality and to compare their performance with the modified Nutrition Risk in the Critically Ill (mNUTRIC) score. Methods: This single-center retrospective study included 319 older adults (aged ≥ 65 years) with AECOPD admitted to the ICU. PNI was calculated at admission and on day 3, and ΔPNI was defined as the difference between these values. The mNUTRIC score was calculated at admission. The primary outcome was ICU mortality. Discriminative performance was assessed using receiver operating characteristic (ROC) analysis. Independent predictors were identified using multivariable logistic regression, and survival was evaluated using Kaplan–Meier and Cox proportional hazards analyses. Results: ICU mortality was 19.8%. The mNUTRIC score demonstrated strong discriminative ability for predicting ICU mortality (AUC 0.852), significantly higher than that of PNI (AUC 0.664; p < 0.0001). In multivariable analysis, the mNUTRIC score remained an independent predictor of ICU mortality (OR 2.50; p < 0.001). Although hypertension was associated with lower mortality in univariate analysis, this association was not confirmed after adjustment for disease severity. In univariate analysis, ΔPNI did not demonstrate significant prognostic value ( p = 0.083), and this was consistent across multivariable logistic regression and Cox proportional hazards analyses. Kaplan–Meier analysis demonstrated significantly poorer survival among patients with high risk (mNUTRIC ≥ 6) (log-rank p < 0.001). In Cox proportional hazards analysis, only mNUTRIC remained independently associated with mortality, whereas neither baseline PNI nor ΔPNI demonstrated an independent association with survival. Conclusion: In older adults with AECOPD requiring ICU admission, baseline multidimensional risk assessment using the mNUTRIC score was strongly associated with ICU mortality. Among patients who survived and remained in the ICU until day 3, early changes in PNI did not provide meaningful additional prognostic information beyond the baseline assessment. The lack of prognostic significance of ΔPNI was consistent across ROC, multivariable logistic regression, and Cox survival analyses. The apparent inverse association between hypertension and mortality was largely explained by disease severity. Further prospective studies incorporating direct measures of frailty are needed to validate these findings.

  • Open Access

    Norepinephrine Dose and Pulse Oximetry Agreement During Critical Illness: A Prospective Repeated-Measures Study

    by Mahmut Yilmaz, Mete Erdemir, Mehmet Celal Ozturk, Rahime Aydin Kayali, Burak Emre Gilik, Mehmet Cuhadar, Huseyin Ozkarakas, Gurhan Taskin, Levent Yamanel

    Background and Objectives: Pulse oximetry is essential in ICUs but may be less accurate when peripheral perfusion is impaired. Norepinephrine, the primary vasopressor for shock, may exacerbate vasoconstriction and microcirculatory alterations, increasing discrepancy between pulse oximetry saturation (SpO2) and arterial oxygen saturation (SaO2). This study aimed to evaluate whether norepinephrine dose is associated with disagreement between SpO2 and SaO2, with particular attention to measurement variability and large discrepancies. Materials and Methods: We analyzed 1050 paired SpO2–SaO2 measurements from 196 adult ICU patients receiving norepinephrine. Dose was weight-adjusted (µg/kg/min). Based on the clinically relevant thresholds defined in the 2021 Surviving Sepsis Campaign guidelines for initiating vasopressin, doses were categorized as low (≤0.25 µg/kg/min), moderate (0.25–0.50 µg/kg/min), or high (≥0.50 µg/kg/min). A large discrepancy was defined as |SpO2 − SaO2| ≥ 5%. A generalized estimating equation (GEE) model was applied to account for repeated measurements within patients. Results: Overall mean bias was 0.91 ± 3.58%. In the primary GEE analysis accounting for repeated measurements within patients, norepinephrine dose was not significantly associated with large SpO2–SaO2 discrepancies when analyzed as a continuous variable (adjusted OR 0.964, 95% CI 0.916–1.014, p = 0.158). Categorical analyses showed a non-monotonic pattern, with only the comparison between the moderate- and high-dose groups reaching statistical significance and with wide confidence intervals limiting the precision of this finding. Unadjusted descriptive analyses suggested greater measurement variability across dose ranges, which was largely attributable to within-patient clustering. ROC analysis demonstrated limited discriminatory ability for norepinephrine dose alone (AUC 0.60). Conclusions: After accounting for repeated measurements and relevant clinical covariates, norepinephrine dose did not demonstrate a consistent dose-dependent association with large SpO2–SaO2 discrepancies. Although large SpO2–SaO2 discrepancies may occur in critically ill patients receiving norepinephrine, norepinephrine infusion rate alone should not be used as a surrogate marker of pulse oximetry reliability.

  • Open Access

    Clinical Determinants of 90-Day Mortality After Tracheostomy in Critically Ill Patients: A Multicenter Retrospective Cohort Study

    by Yakup Özgüngör, Hicret Yeniay, Burak Emre Gilik, Emre Karagöz, Mensure Çakırgöz, Sıla Seven

    Background and Objectives: Tracheostomy is frequently performed in critically ill patients requiring prolonged invasive mechanical ventilation; however, factors associated with intermediate-term mortality after tracheostomy remain poorly characterized. This study aimed to identify clinical and procedural factors associated with 90-day all-cause mortality after tracheostomy in ICU patients. Materials and Methods: This retrospective multicenter cohort study included 292 adult patients who underwent tracheostomy in two tertiary ICUs between 1 October 2023 and 1 June 2025. Demographic characteristics, admission diagnoses, comorbidities, clinical severity scores, procedural variables, microbiological culture results, and survival data were collected. Univariate analyses, multivariable binary logistic regression, Cox proportional hazards regression, receiver operating characteristic (ROC) analysis, and Kaplan–Meier survival analysis were performed. Results: The overall 90-day all-cause mortality rate was 74.7%. Age, Charlson Comorbidity Index, and APACHE II score were significantly associated with 90-day mortality in univariate analyses, whereas tracheostomy timing and technique were not. In multivariable logistic regression analysis, the Charlson Comorbidity Index and APACHE II score were independently associated with mortality. Cox proportional hazards regression confirmed that both APACHE II score and Charlson Comorbidity Index were independently associated with mortality over time. ROC analysis demonstrated moderate discriminative performance for age, Charlson Comorbidity Index, and APACHE II score. Conclusions: In critically ill patients undergoing tracheostomy, 90-day mortality was high and was driven primarily by acute illness severity and comorbidity burden rather than procedural characteristics. These findings support incorporating biological vulnerability, expected recovery potential, and goals-of-care discussions into tracheostomy decision-making.

  • Open Access

    Prognostic Significance of Dynamic Free T3 Changes in Critically Ill Patients

    by Yakup Özgüngör, Burak Emre Gilik, Emre Karagöz, Hicret Yeniay, Mensure Çakırgöz, Özlem Melis Korkmaz Özgüngör, İhsan Birol, Sıla Seven

    Background: Non-thyroidal illness syndrome is frequent in critically ill patients, but the prognostic value of dynamic changes in thyroid function tests remains unclear. This study evaluated whether serial measurements of thyroid-stimulating hormone (TSH) and free triiodothyronine (FT3) provide additional predictive value for 30-day mortality beyond conventional severity scores in ICU patients. Methods: This single-center retrospective observational study included 74 adult patients treated for ≥72 h in a general ICU who had TSH and FT3 measured within 24 h of admission and repeated at 48–72 h. Patients aged 18 years or above admitted to the intensive care unit were included in the study. Demographic characteristics, comorbidities, APACHE II, SOFA, modified NUTRIC (mNUTRIC) scores, and routine laboratory data (including albumin, CRP, and lactate) were recorded. The primary outcome was 30-day mortality. Between-group comparisons were performed using t-tests, Mann–Whitney U, and Chi-square tests. Variables significant in univariate analyses were entered into binary logistic regression models, and predictive performance was assessed using receiver operating characteristic (ROC) curves and the Youden index. Results: The mean age was 68.7 ± 14.7 years, and 41.9% (n = 31) of the patients died within 30 days. Non-survivors had higher APACHE II, SOFA, and mNUTRIC scores and lower albumin, lymphocyte count, and second FT3 levels compared with survivors (all p ≤ 0.003). Baseline FT3 and TSH were not associated with mortality, whereas both the subsequent FT3 measurements and the ΔT3 (variance in former to latter FT3) were remarkably predictive. The latter FT3 < 1.63 pg/mL produced an AUC of 0.835 (sensitivity: 77%, specificity: 74%), and a ΔT3 log ratio threshold of −0.09 (≈20% early FT3 decline) produced an AUC of 0.835 (sensitivity: 71%, specificity: 81%). The APACHE II + ΔT3 (numeric) model showed the best discrimination (AUC: 0.921; sensitivity: 87.1%, specificity: 81.4%), outperforming APACHE II alone (AUC: 0.861). Conclusions: In critically ill adult patients, dynamic T3 kinetics—particularly premature decline in FT3 within the first 72 h—provide incremental prognostic value for 30-day mortality beyond APACHE II. Serial FT3 monitoring may help identify high-risk patients whose endocrine adaptation to critical illness is failing.

  • Open Access

    Impact of Procalcitonin Kinetics on Mortality in Intensive Care Patients with Sepsis

    by Yakup Özgüngör, Burak Emre Gilik, Emre Karagöz, Hicret Yeniay, Mensure Çakırgöz, Özlem Melis Korkmaz Özgüngör, İhsan Birol, Sıla Seven

    Background and Objectives: Procalcitonin (PCT) kinetics are increasingly used as prognostic markers in sepsis, but their interpretation is confounded by dynamic changes in renal function during acute illness. This study evaluated the prognostic value of ΔPCT for 30-day mortality in critically ill patients with either sepsis or septic shock by incorporating serial kinetic eGFR measurements and renal function-adjusted ΔPCT cut-off values based on the mean kinetic eGFR during the first 48–72 h of ICU admission. Materials and Methods: This retrospective cohort study included 106 adult ICU patients with either sepsis or septic shock. Serial procalcitonin measurements were used to calculate ΔPCT as a ratio of follow-up to baseline values, while renal function was assessed using mean kinetic eGFR over the first 72 h of ICU admission. Results: Thirty-day mortality was 43.4%. ΔPCT was a strong independent predictor of mortality across all models. At 48 h, ΔPCT2 was independently associated with 30-day mortality in the overall cohort (AUC 0.793) and demonstrated independent prognostic significance only in patients with preserved renal function (GFR ≥ 30 mL/min/1.73 m2). The optimal ΔPCT2 cut-off corresponded to a 56% reduction in procalcitonin levels. At 72 h, ΔPCT3 emerged as an independent predictor of mortality regardless of renal function. ROC analysis identified an optimal ΔPCT3 cut-off corresponding to 62% procalcitonin reduction in the overall cohort, with renal function-specific thresholds of ~50% for patients with GFR < 30 mL/min/1.73 m2 and ~73% for those with preserved renal function. The combination of APACHE II score and ΔPCT3 demonstrated the highest discriminative performance for mortality prediction (AUC 0.948). Conclusions: Procalcitonin kinetics provide clinically meaningful prognostic information in sepsis when interpreted alongside dynamic renal function. While 48 h procalcitonin kinetics offer prognostic value primarily in patients with preserved renal function, 72 h ΔPCT provides renal function-independent and superior mortality discrimination. Integrating serial kinetic eGFR measurements enables renal function-adapted ΔPCT threshold determination and may improve risk stratification in critically ill septic patients.


  • Open Access

    Impact of Procalcitonin Kinetics on Mortality in Intensive Care Patients with Sepsis

    by Yakup Özgüngör, Burak Emre Gilik, Emre Karagöz, Hicret Yeniay, Mensure Çakırgöz, Özlem Melis Korkmaz Özgüngör, İhsan Birol, Sıla Seven

    Background and Objectives: Procalcitonin (PCT) kinetics are increasingly used as prognostic markers in sepsis, but their interpretation is confounded by dynamic changes in renal function during acute illness. This study evaluated the prognostic value of ΔPCT for 30-day mortality in critically ill patients with sepsis or septic shock by incorporating serial kinetic eGFR measurements and renal function–adjusted ΔPCT cut-off values based on the mean kinetic eGFR during the first 48-72 hours of ICU admission. Materials and Methods: This retrospective cohort study included 106 adult ICU patients with sepsis or septic shock. Serial procalcitonin measurements were used to calculate ΔPCT as ratio of follow-up to baseline values, while renal function was assessed using mean kinetic eGFR over the first 72 hours of ICU admission. Results: Thirty-day mortality was 43.4%. ΔPCT was a strong independent predictor of mortality across all models. At 48 hours, ΔPCT2 was independently associated with 30-day mortality in the overall cohort (AUC 0.793) and retained independent prognostic significance only in patients with preserved renal function (GFR ≥30 mL/min/1.73 m²). The optimal ΔPCT2 cut-off corresponded to a 56% reduction in procalcitonin levels. At 72 hours, ΔPCT3 emerged as an independent predictor of mortality regardless of renal function. ROC analysis identified an optimal ΔPCT3 cut-off corresponding to 62% procalcitonin reduction in the overall cohort, with renal function–specific thresholds of ~50% for patients with GFR

  • Open Access

    Thyroid Hormone Kinetics: Prognostic Significance of Dynamic TSH and Free T3 Changes in Critically Ill Patients

    by Yakup Özgüngör, Burak Emre Gilik, Emre Karagöz, Mensure Çakırgöz

    Background : Non-thyroidal illness syndrome is frequent in critically ill patients, but the prognostic value of dynamic changes in thyroid function tests remains unclear. This study evaluated whether serial measurements of thyroid-stimulating hormone (TSH) and free triiodothyronine (FT3) provide additional predictive value for 30-day mortality beyond conventional severity scores in ICU patients. Methods : This single-center retrospective observational study included 74 adult patients treated for ≥72 hours in a general ICU who had TSH and FT3 measured within 24 hours of admission and again at 48–72 hours. Demographic characteristics, comorbidities, APACHE II, SOFA, modified NUTRIC (mNUTRIC) scores, and routine laboratory data (including albumin, CRP, and lactate) were recorded. The primary outcome was 30-day mortality. Between-group comparisons were performed using t-tests, Mann–Whitney U, and Chi-square tests. Variables significant in univariate analyses were entered into binary logistic regression models, and predictive performance was assessed using receiver operating characteristic (ROC) curves and the Youden index. Results: The mean age was 68.7 ± 14.7 years, and 41.9% (n = 31) of patients died within 30 days. Non-survivors had higher APACHE II, SOFA, and mNUTRIC scores and lower albumin, lymphocyte count, and second FT3 levels compared with survivors (all p ≤ 0.003). Baseline FT3 and TSH were not associated with mortality, whereas both the second FT3 measurement and the ΔT3 (second–first FT3) were strongly predictive. Second FT3 <1.63 pg/mL yielded an AUC of 0.835 (sensitivity 77%, specificity 74%), and a ΔT3 log ratio threshold of –0.09 (≈20% early FT3 decline) produced an AUC of 0.835 (sensitivity 71%, specificity 81%). The APACHE II + ΔT3 (numeric) model showed the best discrimination (AUC 0.921; sensitivity 87.1%, specificity 81.4%), outperforming APACHE II alone (AUC 0.861). Conclusions : In critically ill adults, dynamic T3 kinetics—particularly early decline in FT3 within the first 72 hours—provide substantial incremental prognostic value for 30-day mortality beyond APACHE II. Serial FT3 monitoring may help identify high-risk patients whose endocrine adaptation to critical illness is failing.